Ocugen, Inc. (OCGN)
1.395
-0.06
(-4.45%)
USD |
NASDAQ |
May 15, 16:00
1.395
0.00 (0.00%)
After-Hours: 16:50
Ocugen Shareholders Equity (Quarterly) : 5.805M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| REGENXBIO, Inc. | 21.08M |
| Catalyst Pharmaceuticals, Inc. | 1.013B |
| Sarepta Therapeutics, Inc. | 1.505B |
| Krystal Biotech, Inc. | 1.277B |
| Gilead Sciences, Inc. | 23.52B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 56.90M |
| Total Liabilities (Quarterly) | 51.10M |
| Debt to Equity Ratio | 5.736 |
| Current Ratio | 1.862 |
| Net Debt Paydown Yield | -0.03% |